SalutarisMD Data for Wet AMD Treatment with Long Term Positive Outcomes Presented at The Royal College of Ophthalmologists Annual Congress
5/22/2013 6:48:37 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
At The Royal College of Ophthalmologists Annual Congress yesterday, results were presented from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices, Ltd. (SalutarisMD®) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
Help employers find you! Check out all the jobs and post your resume.
comments powered by